What caused the pre-market move in 4570.T stock?

The pre-market jump to **JPY 2,025.00** reflects heavy volume and renewed investor interest in Immuno-Biological Laboratories’ reagent and diagnostic services. Short-term sentiment and sector strength in Healthcare amplified the move ahead of upcoming earnings.

How does valuation look for 4570.T stock?

Valuation is premium: trailing PE **59.06**, P/B **9.14** and P/S **14.97**. Strong margins and cash mitigate some risk, but earnings growth must keep pace to justify current multiples.

What are realistic price targets for 4570.T stock?

Meyka frames a Bear **JPY 900.00**, Base **JPY 2,200.00**, and Bull **JPY 3,600.00**. Targets reflect scenarios for revenue scale, margin improvement, and successful commercialization.

When is the next important date for 4570.T stock investors?

The next key date is the earnings announcement on **2026-05-20**, which should provide fresh guidance on revenue, EPS trends and R&D progress for Immuno-Biological Laboratories.

JP Stocks

18 Feb 2026 pre-market: 4570.T Immuno-Biological Lab. (JPX) +24.62%: volume spike

ByHuzaifa Zahoor February 18, 2026February 18, 2026

The most important fact: 4570.T stock jumps 24.62% in pre-market trading on 18 Feb 2026, trading at JPY 2,025.00 on volume of 4,322,800 shares. This high-volume move on the JPX follows an intraday range between JPY 1,729.00 and JPY 2,025.00, with the 50-day average at JPY 1,628.76. We examine what the surge means for valuations, momentum and near-term price targets for Immuno-Biological Laboratories Co., Ltd.